Back to Journals » Breast Cancer: Targets and Therapy » Volume 4
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Corrigendum
Published 30 December 2011 Volume 2012:4 Pages 1—2
Menis J, Twelves C
Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer
Breast Cancer (London). 2011;3:101–111.
Professor Twelves has received honoraria from Eisai.
© 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.